Dr. Lal PathLabs Limited (LALPATHLAB.NS)
INR 3018.6
(-0.67%)
INR 3018.6
(-0.67%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 1.03 Billion INR | -51.71% |
| 2022 | 2.13 Billion INR | -30.19% |
| 2021 | 3.05 Billion INR | 177.36% |
| 2020 | 1.1 Billion INR | 18.48% |
| 2019 | 929.72 Million INR | 0.0% |
| 2018 | - INR | 100.0% |
| 2017 | -22.73 Million INR | -86.42% |
| 2016 | -12.19 Million INR | -12.73% |
| 2015 | -10.81 Million INR | 0.0% |
| 2014 | - INR | -100.0% |
| 2013 | 76.9 Million INR | 0.0% |
| 2012 | - INR | 0.0% |
| 2011 | - INR | -100.0% |
| 2010 | 41.31 Million INR | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q1 | - INR | 0.0% |
| 2024 Q2 | - INR | 0.0% |
| 2023 FY | 1.03 Billion INR | -51.71% |
| 2023 Q1 | - INR | -100.0% |
| 2023 Q3 | - INR | -100.0% |
| 2023 Q2 | 1.65 Billion INR | 0.0% |
| 2023 Q4 | 1.03 Billion INR | 0.0% |
| 2022 Q2 | 2.66 Billion INR | 0.0% |
| 2022 Q4 | 2.13 Billion INR | 0.0% |
| 2022 Q1 | - INR | -100.0% |
| 2022 FY | 2.13 Billion INR | -30.19% |
| 2022 Q3 | - INR | -100.0% |
| 2021 Q3 | - INR | -100.0% |
| 2021 Q1 | - INR | -100.0% |
| 2021 FY | 3.05 Billion INR | 177.36% |
| 2021 Q4 | 3.05 Billion INR | 0.0% |
| 2021 Q2 | 1.12 Billion INR | 0.0% |
| 2020 Q3 | - INR | -100.0% |
| 2020 Q4 | 1.1 Billion INR | 0.0% |
| 2020 Q2 | 1 Million INR | 0.0% |
| 2020 Q1 | - INR | -100.0% |
| 2020 FY | 1.1 Billion INR | 18.48% |
| 2019 Q1 | - INR | 0.0% |
| 2019 Q3 | - INR | 0.0% |
| 2019 FY | 929.72 Million INR | 0.0% |
| 2019 Q4 | 929.72 Million INR | 0.0% |
| 2019 Q2 | - INR | 0.0% |
| 2018 Q2 | - INR | 0.0% |
| 2018 FY | - INR | 100.0% |
| 2018 Q4 | - INR | 0.0% |
| 2018 Q3 | - INR | 0.0% |
| 2018 Q1 | - INR | 0.0% |
| 2017 FY | -22.73 Million INR | -86.42% |
| 2017 Q1 | - INR | 0.0% |
| 2017 Q2 | - INR | 0.0% |
| 2017 Q3 | - INR | 0.0% |
| 2017 Q4 | - INR | 0.0% |
| 2016 FY | -12.19 Million INR | -12.73% |
| 2016 Q3 | - INR | 0.0% |
| 2016 Q4 | - INR | 0.0% |
| 2016 Q2 | - INR | 0.0% |
| 2016 Q1 | - INR | 0.0% |
| 2015 Q4 | - INR | 0.0% |
| 2015 Q2 | - INR | 0.0% |
| 2015 Q1 | - INR | 0.0% |
| 2015 FY | -10.81 Million INR | 0.0% |
| 2014 FY | - INR | -100.0% |
| 2014 Q4 | - INR | 0.0% |
| 2013 FY | 76.9 Million INR | 0.0% |
| 2012 FY | - INR | 0.0% |
| 2011 FY | - INR | -100.0% |
| 2010 FY | 41.31 Million INR | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| Krsnaa Diagnostics Limited | 55 Million INR | -1772.727% |
| Metropolis Healthcare Limited | 1.19 Billion INR | 13.495% |
| Thyrocare Technologies Limited | 109.1 Million INR | -844.088% |
| Vijaya Diagnostic Centre Limited | 2.39 Billion INR | 56.913% |
| Vimta Labs Limited | 90.74 Million INR | -1035.111% |